©2024 Stanford Medicine
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
Not Recruiting
Trial ID: NCT01541358
Purpose
This clinical trial studies fluorine F-18 sodium fluoride positron emission tomography
(PET)/computed tomography (CT) in diagnosing bone tumors in patients with cancer. Diagnostic
procedures, such as fluorine F-18 sodium fluoride PET/CT, may help find and diagnose bone
cancer
Official Title
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
Eligibility
Inclusion Criteria:
- Patients referred for evaluation of suspected skeletal cancer
- Patients must understand and voluntarily sign an informed consent form after the
contents have been fully explained to them
Exclusion Criteria:
- Patients who cannot complete a PET/CT scan
- Pregnant women
- Healthy volunteers
Intervention(s):
radiation: fluorine F 18 sodium fluoride
procedure: positron emission tomography/computed tomography
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
ccto-office@stanford.edu
650-498-7061